Marugame Tomomi, Lee Kyongyeon, Eguchi Hiroyuki, Oda Takashi, Shinchi Koichi, Kono Suminori
Department of Preventive Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Cancer Causes Control. 2002 Dec;13(10):917-21. doi: 10.1023/a:1021967301138.
Because a link between hyperinsulinemia and colorectal carcinogenesis has been hypothesized, we explored the relation between glucose tolerance status and colorectal adenomas.
We conducted a case-control study of 560 cases of histologically confirmed colorectal adenomas and 829 controls of normal total colonoscopy in Japanese middle-aged men. Subjects were classified into normal, impaired fasting glucose (IFG), impaired glucose tolerance (IGT), newly diagnosed type 2 diabetes mellitus (DM), and known DM based on fasting blood glucose, 75 g glucose tolerance test, and medical history. Odds ratios (ORs) and 95% confidence intervals (CIs) were obtained from logistic regression analysis with subjects with normal glucose tolerance and IFG as a referent group.
IGT, new type 2 DM, and known DM were each associated with a modest increase in the risk of colorectal adenomas after adjustment for possible confounding factors. An increased risk of large, but not small, adenomas was observed among men with IGT and new type 2 DM. An increased risk associated with new type 2 DM was observed for proximal adenomas only.
Not only type 2 DM but also IGT is associated with increased risk of colorectal adenomas. Hyperinsulinemia may be involved in colorectal carcinogenesis.
由于已推测高胰岛素血症与结直肠癌发生之间存在联系,我们探讨了糖耐量状态与结直肠腺瘤之间的关系。
我们对560例经组织学确诊的结直肠腺瘤患者和829例接受正常全结肠镜检查的日本中年男性对照进行了病例对照研究。根据空腹血糖、75克葡萄糖耐量试验和病史,将受试者分为正常、空腹血糖受损(IFG)、糖耐量受损(IGT)、新诊断的2型糖尿病(DM)和已知DM。以糖耐量正常和IFG的受试者作为参照组,通过逻辑回归分析获得比值比(OR)和95%置信区间(CI)。
在对可能的混杂因素进行调整后,IGT、新诊断的2型DM和已知DM均与结直肠腺瘤风险适度增加相关。在IGT和新诊断的2型DM男性中,观察到较大腺瘤(而非较小腺瘤)的风险增加。仅在近端腺瘤中观察到与新诊断的2型DM相关的风险增加。
不仅2型DM,而且IGT都与结直肠腺瘤风险增加相关。高胰岛素血症可能参与了结直肠癌的发生。